Login / Signup

Estimating the Incidence-Based Cost of Illness Due to Hematopoietic Stem Cell Transplantation Using One-Year Insurance Claim Data in Korea.

Sol KwonHye-Young Kang
Published in: PharmacoEconomics - open (2022)
This study describes an alternative method for conducting incidence-based COI studies using cross-sectional claims data.
Keyphrases
  • cross sectional
  • electronic health record
  • risk factors
  • health insurance
  • big data
  • acute myeloid leukemia
  • machine learning
  • affordable care act
  • artificial intelligence
  • long term care